Medusa 19

Certificate verification page

Certification scheme

98/79/EC Annex III section 6

Certificate number

IVDD 21 048 0109

Certificate history

IVDD 21 048 0109 (Initial issue | 21.Dec.2021)

Manufacturer/Holder of certificate

Medusa 19 Life Sciences Ltd.

Kemp House, 160 City Road, London, EC1V2NX, United Kingdom

Other sites
Effective from

21.Dec.2021

Valid until

26.May.2022

Suspension period
Withdrawn on
Validity status
Valid
Validity conditions

The manufacturer has a duty to submit to the Notified body testing results as per established procedure of each manufactured batch prior its releasing.

Products within scope

Medusa SARS-CoV-2 Antigen Lateral Flow Test

 

The Medusa SARS-CoV-2 lateral flow antigen test is a qualitative in vitro diagnostic (IVD) test to detect SARS-CoV-2 antigen in human anterior nasal swab samples. The test is to be usedto identify individuals with higher viral loads of SARS-CoV-2 that increase the likelihood of transmittingthe infection to others.

Types/Categories/Models:
AVST001 (nasal)
1 test/package
Classification

Devices for self-testing